Anna Lechanteur
- Molecular Biology
- Pharmaceutical Science top 0.5%
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Food Science top 5%
- Co-authors
- Brigitte ÉvrardGéraldine PielOlivier JennotteBruno SarmentoRasmané SemdéDenis MottetJosé das NevesAndreia Almeida
- Topics
- Drug Solubulity and Delivery Systems (14 papers)RNA Interference and Gene Delivery (13 papers)3D Printing in Biomedical Research (11 papers)
- Journals
- SHILAP Revista de lepidopterologíaAdvanced Drug Delivery ReviewsJournal of Controlled Release
- Partner nations
- BelgiumPortugalBurkina Faso
In The Last Decade
Anna Lechanteur
54 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Biology 478
- Pharmaceutical Science 470
- Biomedical Engineering 341
- Biomaterials 265
- Food Science 182
Countries citing papers authored by Anna Lechanteur
This map shows the geographic impact of Anna Lechanteur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lechanteur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lechanteur more than expected).
Fields of papers citing papers by Anna Lechanteur
This network shows the impact of papers produced by Anna Lechanteur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lechanteur. The network helps show where Anna Lechanteur may publish in the future.
Co-authorship network of co-authors of Anna Lechanteur
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lechanteur. A scholar is included among the top collaborators of Anna Lechanteur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lechanteur. Anna Lechanteur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 11 | |
| 8 | 1 | |
| 9 | 22 | |
| 10 | 5 | |
| 11 | 15 | |
| 12 | 9 | |
| 13 | 23 | |
| 14 | 12 | |
| 15 | 25 | |
| 16 | 13 | |
| 17 | 36 | |
| 18 | 36 | |
| 19 | 50 | |
| 20 | 37 |
About Anna Lechanteur
Anna Lechanteur is a scholar working on Pharmaceutical Science, Biomaterials and Food Science, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (14 papers), RNA Interference and Gene Delivery (13 papers) and 3D Printing in Biomedical Research (11 papers). The work is most often cited by research in Pharmaceutical Science (470 citations), Biomaterials (265 citations) and Automotive Engineering (157 citations). Anna Lechanteur has collaborated with scholars based in Belgium, Portugal and Burkina Faso. Frequent co-authors include Brigitte Évrard, Géraldine Piel, Olivier Jennotte, Bruno Sarmento, Rasmané Semdé, Denis Mottet, José das Neves, Andreia Almeida, Najeh Maissar Khalil and Rubiana Mara Mainardes. Their work appears in journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.